PAH News

August 23, 2017August 23, 2017

VMS Heart Analysis System Accurately Evaluates Right Ventricle Remodeling in PH Patients, Study Shows

News, PAH News, PH News

Ventripoint Diagnostics‘ VMS Heart Analysis System, which produces a two-dimensional (2D) volumetric reconstruction model of the heart, accurately measures small changes in the heart’s right ventricle volume and can be used in ... Read more

August 22, 2017August 22, 2017

Estrogen Inhibitors Can Prevent and Treat PAH in Mice, Vanderbilt Study Finds

News, PAH News

Estrogen inhibitors may treat pulmonary vascular disease by correcting metabolic defects in women with pulmonary arterial hypertension (PAH), say researchers at Nashville’s Vanderbilt University. Their study,“Oestrogen inhibition reverses pulmonary arterial hypertension ... Read more

August 21, 2017August 21, 2017

Lab Study Shows Positive Effects of Adcirca in Treatment of PAH

News, PAH News

Adcirca (tadalafil) exerts a variety of positive effects that may explain why the therapy improves idiopathic pulmonary arterial hypertension (IPAH), according to an in vitro study. The study, “Tadalafil ... Read more

August 18, 2017August 18, 2017

Sprycel-induced PAH Seen to Persist for Years in Sizable Number of Leukemia Patients in Study

News, PAH News

A treatment given people with chronic myelogenous leukemia (CML) — Sprycel (dasatinib) — is known to cause pulmonary arterial hypertension (PAH) in some. Now, researchers in France report that PAH ... Read more

August 16, 2017August 16, 2017

Reviva’s RP5063 Prevented Rats from Developing Pulmonary Hypertension, Study Reports

News, PAH News

Reviva Pharmaceuticals‘ RP5063 prevented rats from developing pulmonary arterial hypertension (PAH), according to a Canadian study. In addition to precluding heart and blood vessel damage in the animals, RP5063 decreased levels ... Read more

August 14, 2017August 14, 2017

Tracking Long-term Changes in PAH Patients’ Heart Conditions Could Help Reduce Deaths, Study Suggests

News, PAH News

Tracking long-term changes in measurements associated with pulmonary hypertension patients’ death from heart disease can help doctors do a better job of identifying those at higher risk of such ... Read more

July 28, 2017July 28, 2017

Complexa Raises $62 Million to Continue Trials of Its Pulmonary Hypertension Therapy CXA-10

News, PAH News

Complexa has obtained $62 million in financing to continue advancing its pulmonary arterial hypertension therapy CXA-10 through the clinical trial process. The company is also developing CXA-10 as a treatment ... Read more

July 27, 2017July 27, 2017

Survival Rate Is Higher for PH Patients Who Are Put on a Transplant Priority List, Study Shows

News, PAH News, PH News

The survival rate of pulmonary hypertension patients who received heart and lung transplants increased after France began giving transplant priority to those experiencing life-threatening episodes, a study reports. The ... Read more

July 26, 2017July 26, 2017

Long-term Prostacyclin Use Increases Risk of a Heart Problem After a Lung Transplant, Study Reports

News, PAH News

Pulmonary hypertension patients who receive prostacyclin for a long time are at higher risk of developing cardiovascular complications after a lung transplant, a Japanese study reports. The research, published in ... Read more

July 24, 2017July 26, 2017

Two Pulmonary Hypertension Groups Sign Up for ZappRx’s Streamlined Prescription-ordering Service

News, PAH News, PH News

Two pulmonary hypertension treatment groups are now working with a company that helps doctors to streamline the complex process of obtaining insurance company sign-offs on speciality prescriptions, which can take weeks. Arizona Pulmonary Specialists in Phoenix ... Read more